SCHEMBL1256569

SCHEMBL1256569

CC1C[C]C(C(C)C)CC1

nearest known ligand 0.37

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 2/20 0.37
TRPM8 Q7Z2W7 2/20 0.37
EPHX1 P07099 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Isobutane SCHEMBL10336228 0.64
SCHEMBL12475485 0.63
SCHEMBL5614202 0.60
SCHEMBL1167455 0.60
SCHEMBL5613975 0.60
SCHEMBL8658250 0.59
SCHEMBL1182 0.59
SCHEMBL6503534 0.59 TRPM8 (0.56) TRPA1TRPM8EPHX1
SCHEMBL15799172 0.59
SCHEMBL30604482 0.58 TRPM8 (0.62) TRPA1TRPM8EPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2931228-B1 ETHANOL-FREE MICROEMULSION PERFUMING COMPOSITIONS. FIRMENICH & CIE (CH) 2018-01-31 EP claimed
US-20170267943-A1 ETHANOL-FREE MICROEMULSION PERFUMING COMPOSITIONS FIRMENICH SA (CH) 2017-09-21 US claimed
US-9701924-B2 Ethanol-free microemulsion perfuming compositions FIRMENICH SA (CH) 2017-07-11 US claimed
US-20150322374-A1 ETHANOL-FREE MICROEMULSION PERFUMING COMPOSITIONS FIRMENICH SA (CH) 2015-11-12 US claimed
EP-2931228-A1 ETHANOL-FREE MICROEMULSION PERFUMING COMPOSITIONS Firmenich SA (CH) 2015-10-21 EP claimed
WO-2014090959-A1 ETHANOL-FREE MICROEMULSION PERFUMING COMPOSITIONS FIRMENICH SA (CH) 2014-06-19 WO claimed
EP-2155151-B1 Butanone derivatives and use thereof as cooling agents GIVAUDAN SA (CH) 2013-07-31 EP claimed
EP-2178836-B1 AMIDE ADDITION REACTION GIVAUDAN SA (CH) 2013-04-17 EP claimed
US-7880011-B2 reacting p-menthanecarboxamide in toluene with 2-vinyl pyridine, 18-crown-6 chelating agent , potassium tert-butoxide (20% in tetrahydrofuran), heating to produce N-(2-pyridin-2-ylethyl)p-menthanecarboxamide[(1R,2S,5R)-2-isopropyl-5-methyl-N-(2-(pyridin-2-yl)ethyl)cyclohexanecarboxamide Givandan, S.A. (CH) 2011-02-01 US claimed
US-20100197713-A1 BUTONE DERIVATIVES USEFUL AS COOLING AGENTS GIVAUDAN SA (CH) 2010-08-05 US claimed
EP-2178836-A1 AMIDE ADDITION REACTION Givaudan SA (CH) 2010-04-28 EP claimed
EP-2155151-A2 ORGANIC COMPOUNDS Givaudan SA (CH) 2010-02-24 EP claimed
WO-2009012609-A1 AMIDE ADDITION REACTION GIVAUDAN SA (CH) 2009-01-29 WO claimed
US-20090030042-A1 Amide Addition Reaction GIVAUDAN, SA. (CH) 2009-01-29 US claimed
WO-2008141469-A2 BUTONE DERIVATIVES USEFUL AS COOLING AGENTS GIVAUDAN SA (CH) 2008-11-27 WO claimed
US-9976108-B2 Ethanol-free microemulsion perfuming compositions FIRMENICH SA (CH) 2018-05-22 US disclosed
EP-2931228-B1 ETHANOL-FREE MICROEMULSION PERFUMING COMPOSITIONS. FIRMENICH & CIE (CH) 2018-01-31 EP disclosed
WO-2009012609-A1 AMIDE ADDITION REACTION GIVAUDAN SA (CH) 2009-01-29 WO disclosed
US-20090030042-A1 Amide Addition Reaction GIVAUDAN, SA. (CH) 2009-01-29 US disclosed
WO-2008141469-A2 BUTONE DERIVATIVES USEFUL AS COOLING AGENTS GIVAUDAN SA (CH) 2008-11-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100197713-A1 BUTONE DERIVATIVES USEFUL AS COOLING AGENTS C1S, HSD3B1, DECR1 TRPA1 1136/4885TRPM8 3493/4885EPHX1 2855/4885
US-20090030042-A1 Amide Addition Reaction HRH2, OGDH, MDH2 TRPA1 3736/4885TRPM8 4278/4885EPHX1 757/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.